WallStSmart

Comcast Corp (CMCSA)vsSanofi ADR (SNY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Comcast Corp generates 165% more annual revenue ($123.71B vs $46.72B). SNY leads profitability with a 16.7% profit margin vs 16.2%. SNY appears more attractively valued with a PEG of 4.32. CMCSA earns a higher WallStSmart Score of 62/100 (C+).

CMCSA

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 7.0Value: 6.0Quality: 6.0
Piotroski: 6/9Altman Z: 1.48

SNY

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 6.0Value: 4.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CMCSAUndervalued (+11.4%)

Margin of Safety

+11.4%

Fair Value

$36.65

Current Price

$28.73

$7.92 discount

UndervaluedFair: $36.65Overvalued
SNYSignificantly Overvalued (-89.7%)

Margin of Safety

-89.7%

Fair Value

$24.79

Current Price

$46.03

$21.24 premium

UndervaluedFair: $24.79Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CMCSA5 strengths · Avg: 9.2/10
P/E RatioValuation
5.4x10/10

Attractively priced relative to earnings

Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Market CapQuality
$106.47B9/10

Large-cap with strong market position

Return on EquityProfitability
21.4%9/10

Every $100 of equity generates 21 in profit

Free Cash FlowQuality
$5.09B8/10

Generating 5.1B in free cash flow

SNY3 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Market CapQuality
$109.03B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.59B8/10

Generating 1.6B in free cash flow

Areas to Watch

CMCSA4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
1.2%4/10

1.2% revenue growth

Debt/EquityHealth
1.143/10

Elevated debt levels

PEG RatioValuation
142.982/10

Expensive relative to growth rate

EPS GrowthGrowth
-52.5%2/10

Earnings declined 52.5%

SNY3 concerns · Avg: 3.0/10
EPS GrowthGrowth
2.4%4/10

2.4% earnings growth

Return on EquityProfitability
6.7%3/10

ROE of 6.7% — below average capital efficiency

PEG RatioValuation
4.322/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CMCSA

The strongest argument for CMCSA centers on P/E Ratio, Price/Book, Market Cap. Profitability is solid with margins at 16.2% and operating margin at 10.8%.

Bull Case : SNY

The strongest argument for SNY centers on Price/Book, Market Cap, Free Cash Flow. Profitability is solid with margins at 16.7% and operating margin at 14.3%.

Bear Case : CMCSA

The primary concerns for CMCSA are Revenue Growth, Debt/Equity, PEG Ratio.

Bear Case : SNY

The primary concerns for SNY are EPS Growth, Return on Equity, PEG Ratio.

Key Dynamics to Monitor

CMCSA profiles as a value stock while SNY is a mature play — different risk/reward profiles.

CMCSA carries more volatility with a beta of 0.78 — expect wider price swings.

SNY is growing revenue faster at 6.9% — sustainability is the question.

CMCSA generates stronger free cash flow (5.1B), providing more financial flexibility.

Bottom Line

CMCSA scores higher overall (62/100 vs 49/100), backed by strong 16.2% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Comcast Corp

COMMUNICATION SERVICES · TELECOM SERVICES · USA

Comcast Corporation is an American telecommunications conglomerate headquartered in Philadelphia, Pennsylvania. It is the second-largest broadcasting and cable television company in the world by revenue (behind AT&T), the largest pay-TV company, the largest cable TV company and largest home Internet service provider in the United States, and the nation's third-largest home telephone service provider. Comcast provides services to U.S. residential and commercial customers in 40 states and in the District of Columbia. As the parent company of the international media company NBCUniversal since 2011, Comcast is a producer of feature films and television programs intended for theatrical exhibition and over-the-air and cable television broadcast, respectively.

Visit Website →

Sanofi ADR

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.

Want to dig deeper into these stocks?